doi:10.1016/j.jaad.2013.01.032 23Cacoub P, Musette P, Descamps V,
The arginate salt choice is ProHealth's deliberate formulation decision for this product
It has FDA approval history for specific pediatric indications and has long been used in certain clinical settings where healthcare providers evaluate growth hormone-related concerns in adults
In tumor cells, oncogenes, tumor suppressor genes, and non-coding ncRNAs alter Gln metabolism by directly or indirectly regulating the expression and enzymatic activity of Gln-related genes
Speak with a licensed provider through our platform and find out whether prescription-based treatments could be the right next step for you
Akinori A, Yutaka T, Yuko S, Takeharu Y